Abstract: A method is provided for treating an individual for a malarial infection, in particular drug-resistant species of Plasmodium, including administering to the individual in need of such treatment a composition comprising an extract containing an effective amount of one or more anti-malarial di- or tri-terpene compounds. Potent and effective extracts containing the anti-malarial compounds can be derived from Luo Han fruit and Stevia leaves, including combinations of the same, for treating and preventing malaria in an inexpensive manner from readily available commodities. The composition may be administered orally in a solid or liquid ingestible form.
Type:
Application
Filed:
March 16, 2018
Publication date:
July 26, 2018
Applicant:
Febris Bio-Tech Limited
Inventors:
Garth Selwyn SMITH, Lixin ZHANG, Huanqin DAI
Abstract: A method is provided for treating an individual for a malarial infection, in particular drug-resistant species of Plasmodium, including administering to the individual in need of such treatment a composition comprising an extract containing an effective amount of one or more anti-malarial di- or tri-terpene compounds. Potent and effective extracts containing the anti-malarial compounds can be derived from Luo Han fruit and Stevia leaves, including combinations of the same, for the purpose of treating and preventing malaria in an inexpensive manner from readily available commodities. In one embodiment, the composition is administered orally in a solid or liquid ingestible form.
Type:
Grant
Filed:
September 10, 2011
Date of Patent:
April 17, 2018
Assignee:
Febris Bio-Tech Limited
Inventors:
Garth Selwyn Smith, Lixin Zhang, Huanqin Dai
Abstract: A method is provided for treating an individual for a malarial infection, in particular drug-resistant species of Plasmodium, including administering to the individual in need of such treatment a composition comprising an extract containing an effective amount of one or more anti-malarial di- or tri-terpene compounds. Potent and effective extracts containing the anti-malarial compounds can be derived from Luo Han fruit and Stevia leaves, including combinations of the same, for the purpose of treating and preventing malaria in an inexpensive manner from readily available commodities. In one embodiment, the composition is administered orally in a solid or liquid ingestible form.
Type:
Application
Filed:
September 10, 2011
Publication date:
March 13, 2014
Applicant:
FEBRIS BIO-TECH LIMITED
Inventors:
Garth Selwyn Smith, Lixin Zhang, Huanqin Dai